Comparison Between Activated Partial Thromboplastin Time and Anti-Xa Heparin Assays on Patients on Unfractionated Heparin Therapy

被引：0
|
作者：
Pearlman, Eugene [1 ]
Bibars, Wafi [2 ]
Willard, Jennifer [3 ]
Moore, Darlene [3 ]
机构：
[1] Vet Affairs Med Ctr, Memphis, TN USA
[2] Univ Tennessee, Hlth Sci Ctr, Knoxville, TN 37996 USA
[3] Vet Affairs Med Ctr Memphis, Memphis, TN USA
来源：
AMERICAN JOURNAL OF CLINICAL PATHOLOGY | 2015年 / 144卷
关键词：
D O I：
10.1093/ajcp/144.suppl2.127
中图分类号：
R36 [病理学];
学科分类号：
100104 ;
摘要：
127
引用
收藏
页码：A127 / A127
页数：1
相关论文
共 50 条
  • [31] MONITORING HEPARIN-THERAPY - RELATIONSHIPS BETWEEN THE ACTIVATED PARTIAL THROMBOPLASTIN TIME AND HEPARIN ASSAYS BASED ON EXVIVO HEPARIN SAMPLES
    VANDENBESSELAAR, AMHP
    MEEUWISSEBRAUN, J
    BERTINA, RM
    THROMBOSIS AND HAEMOSTASIS, 1990, 63 (01) : 16 - 23
  • [32] Puerperal thromboprophylaxis: comparison of the anti-Xa activity of enoxaparin and unfractionated heparin
    Gibson, JL
    Ekevall, K
    Walker, I
    Greer, IA
    BRITISH JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 1998, 105 (07): : 795 - 797
  • [33] Puerperal thromboprophylaxis: comparison of the anti-Xa activity of enoxaparin and unfractionated heparin
    Laifer, SA
    Casele, HL
    BRITISH JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 1999, 106 (06): : 614 - 615
  • [34] Comparing anti-factor Xa and activated partial thromboplastin levels for monitoring unfractionated heparin.
    Wahking, Rebekah A.
    Hargreaves, Rachel H.
    Lockwood, Sean M.
    Haskell, Sabrina K.
    Davis, Kelly
    PHARMACOTHERAPY, 2018, 38 (07): : E54 - E54
  • [35] From Activated Partial Thromboplastin Time to Antifactor Xa and Back AgainThe Evolution of Monitoring Unfractionated Heparin
    May, Jori E.
    Siniard, Rance Chad
    Taylor, Laura J.
    Marques, Marisa B.
    Gangaraju, Radhika
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2022, 157 (03) : 321 - 327
  • [36] The therapeutic range for heparin therapy: Relationship between six activated partial thromboplastin time reagents and two heparin assays
    Kitchen, S
    Preston, FE
    THROMBOSIS AND HAEMOSTASIS, 1996, 75 (05) : 734 - 739
  • [37] Correlation between activated partial thromboplastin time and anti-Xa activity in patients who received low-molecular weight heparin as anticoagulation for haemodialysis
    Wong, Steve Siu-Man
    Lau, Wai-Yan
    Chan, Ping-Kwan
    Wan, Ching-Kit
    Cheng, Yuk-Lun
    NEPHROLOGY, 2017, 22 (11) : 921 - 924
  • [38] Interlaboratory Precision in the Monitoring of Unfractionated Heparin Using the Anti-Factor Xa-Correlated Activated Partial Thromboplastin Time
    Cuker, Adam
    Ptashkin, Beverly
    Konkle, Barbara A.
    Pipe, Steven W.
    Whinna, Herbert C.
    Zheng, X. Long
    Cines, Douglas B.
    Pollak, Eleanor
    BLOOD, 2008, 112 (11) : 166 - 166
  • [39] Stability of the activated partial thromboplastin time used to monitor unfractionated heparin
    Ray, M.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2008, 6 (10) : 1817 - 1819
  • [40] Interlaboratory agreement in the monitoring of unfractionated heparin using the anti-factor Xa-correlated activated partial thromboplastin time
    Cuker, A.
    Ptashkin, B.
    Konkle, B. A.
    Pipe, S. W.
    Whinna, H. C.
    Zheng, X. L.
    Cines, D. B.
    Pollak, E. S.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2009, 7 (01) : 80 - 86
12345